⭐️ Check Odoo - https://www.odoo.com/r/kr0 ⭐️ Think School’s flagship Communication course with live doubt sessions : https://thethinkschool.com/sp/communication-masterclass/ ⭐️Spotify Link: https://open.spotify.com/episode/4vdskA8N3MGhnJK0agTzmn?si=ycPfAnBdRMKJTfTyK4A39g If you are a copyright owner and believe your work has been used improperly, please contact us at writers@thethinkschool.com for prompt removal or credit. Follow Our Guests - Jitendra Chouksey (JC): https://www.instagram.com/fittrwithjc/ Arjun Garewal: https://www.instagram.com/arjungarewal/ Dr. Muffazal Lakdawala: https://www.instagram.com/drmuffi/ Research reports cited by JC: DPP trial - https://www.nejm.org/doi/full/10.1056/NEJMoa012512 Barbados study https://pmc.ncbi.nlm.nih.gov/articles/PMC8399825/ BMJ medical error study https://www.bmj.com/content/353/bmj.i2139 GLP-1 discontinuation Oxford study https://www.ox.ac.uk/news/2026-01-08-new-study-finds-stopping-weight-loss-drugs-linked-faster-regain-ending-diet VIDEO INTRODUCTION: India is getting fatter, sicker and more diabetic every year. And now, one injection promises to change everything. GLP-1 drugs like Ozempic are being called a medical breakthrough. They can reduce appetite, accelerate weight loss and help patients control obesity and diabetes. But critics believe these drugs could become a capitalist disaster. One that profits from unhealthy lifestyles while exposing millions of Indians to risks we still do not fully understand. So, is Ozempic a miracle drug or a dangerous shortcut? On one side is Jitendra Chouksey, Founder of FITTR. He believes obesity must primarily be tackled through lifestyle changes and questions the safety, regulation and long-term use of GLP-1 drugs. On the other side are Dr Muffazal Lakdawala, one of India’s leading bariatric surgeons, and Arjun Garewal, a fitness consultant. They believe GLP-1 can transform lives when prescribed to the right patients and combined with proper nutrition, exercise and medical supervision. One drug. Two opposing sides. A decision that could affect millions of Indians. Miracle or disaster? Watch the debate and decide for yourself! Chapters - Watch our previous case studies on GLP1 - India's Drug Goldmine : Can Ozempic make India rich? https://www.youtube.com/watch?v=MTfrEo5duGQ&t=103s Can OZEMPIC make INDIA RICH? | The ₹12,000 Crore Business OPPORTUNITY https://www.youtube.com/watch?v=TDsuhPOMBKs ✅Study Materials: Think School is a Digital School that we all deserved, but never had ►►Check out Think School's Online courses: https://www.thethinkschool.com #ozempic #debate #thinkschool #medical #doctor #glp1 #mounjaro #fatloss #obesity